Sfoglia per Rivista HAEMATOLOGICA
Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases
1990-01-01 Zinzani, P. L.; Lauria, F.; Buzzi, M.; Raspardori, D.; Gugliotta, L.; Bocchia, M.; Macchi, S.; Algeri, R.; Tura, S.
Hematological findings in adult T-cell lymphoma by cytofluorographic analysis. Correlation with histopathology, ultrastructure and immunohistochemistry in 4 cases
1986-01-01 Cintorino, M; Leoncini, L; DEL VECCHIO, Mt; DE SANTI, Mm; Lavarini, E; Musaró, Ma; Tarantino, C
Hematological findings in B-cell lymphoma by cytofluorographic analysis. Correlation wtih morphological findings
1987-01-01 Leoncini, L.; DEL VECCHIO, M. T.; Vindigni, C.; Lavarini, E.; Nuti, S.; Cantore, M.; Cintorino, M.
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2)
2020-01-01 Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R.
Higher levels of reactive oxygen species are associated with anergy in chronic lymphocytic leukemia
2015-01-01 Linley, Adam; Valle Argos, Beatriz; Steele, Andrew J.; Stevenson, Freda K.; Forconi, Francesco; Packham, Graham
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: Impact of the HLA-G 14 base pair (rs66554220) polymorphism
2014-01-01 Rizzo, Roberta; Audrito, Valentina; Vacca, Paola; Rossi, Davide; Brusa, Davide; Stignani, Marina; Bortolotti, Daria; D'Arena, Giovanni; Coscia, Marta; Laurenti, Luca; Forconi, Francesco; Gaidano, Gianluca; Mingari, Maria Cristina; Moretta, Lorenzo; Malavasi, Fabio; Deaglio, Silvia
Hodgkin's disease: Update of findings
1991-01-01 Pileri, S.; Sabattini, E.; Tazzari, P. L.; Gherlinzoni, F.; Zucchini, L.; Bigerna, B.; Leoncini, L.; Rosso, R.; Stein, H.; Falini, B.
Hodgkin’s disease: summary of twenty years of experience
1992-01-01 Mazza, P.; Bocchia, M.; Zinzani, P. L.; Fiacchini, M.; Gherlinzoni, F.; Bandini, G.; Bendandi, M.; Frezza, G. P.; Neri, S.; Barbieri, E.; Tura, S.
How do patients with aggressive non-Hodgkin lymphoma’s treated with third generation regimens fare in the long term?
1999-01-01 Zinzani, P. L.; Martelli, M.; Magagnoli, M.; Zaja, F.; Storti, S.; Pavone, E.; Lauta, V. M.; DE RENZO, Amalia; Gobbi, M.; Bocchia, M.; Ronconi, F.; Scaramucci, L.; Gherlinzoni, F.; Palombi, F.; Bendandi, M.; Stefoni, V.; ANTICOLI BORZA, P.; Cellini, C.; Mandelli, F.; Tura, S.
IGHV1 status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course (Comment to Giudice ID, Foà R. Haematologica. 2019;104(2):219-221)
2019-01-01 Amato, T.; Granai, M.; Leoncini, L.; Bellan, C.
Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study
2007-01-01 Leoncini, Lorenzo; Rondoni, M; Arpinati, M; Paolini, S; Candoni, A; Fanin, R; Messa, E; Pirrotta, MARIA TERESA; Lauria, F.; Visani, G; Alberti, D; Rancati, F; Vinaccia, V; Russo, D; Saglio, G; Baccarani, M; Martinelli, G
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification
2017-01-01 Sutton, Lesley Ann; Hadzidimitriou, Anastasia; Baliakas, Panagiotis; Agathangelidis, Andreas; Langerak, Anton W; Stilgenbauer, Stephan; Pospisilova, Sarka; Davis, Zadie; Forconi, Francesco; Davi, Frederic; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome
2019-01-01 Benagiano, Marisa; Borghi, Maria Orietta; Romagnoli, Jacopo; Mahler, Michael; Della Bella, Chiara; Grassi, Alessia; Capitani, Nagaja; Emmi, Giacomo; Troilo, Arianna; Silvestri, Elena; Emmi, Lorenzo; Alnwaisri, Heba; Bitetti, Jacopo; Tapinassi, Simona; Prisco, Domenico; Baldari, Cosima; Meroni, Pier Luigi; D'Elios, Mario Milco
Intracytoplasmatic and intranuclear filamentous inclusions in a case of acute monocytic leukemia
1986-01-01 Leoncini, L.; Del Vecchio, M. T.; de Santi, M. M.; Cantore, M.; Tarantino, C.
Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia?
2002-01-01 Bocchia, M.; Gentili, S.; Lauria, F.
Localized orbital lymphoma
1997-01-01 Galieni, P.; Polito, E.; Leccisotti, A.; Marotta, G.; Lasi, S.; Bigazzi, C.; Bucalossi, A.; Frezza, G.; Lauria, F.
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: The GIMEMA CML Working Party experience after a 7-year follow-up
2009-01-01 Palandri, Francesca; Castagnetti, Fausto; Alimena, Giuliana; Testoni, Nicoletta; Breccia, Massimo; Luatti, Simona; Rege Cambrin, Giovanna; Stagno, Fabio; Specchia, Giorgina; Martino, Bruno; Levato, Luciano; Merante, Serena; Liberati, Anna Maria; Pane, Fabrizio; Saglio, Giuseppe; Alberti, Daniele; Martinelli, Giovanni; Baccarani, Michele; Rosti, Gianantonio; GIMEMA CML Working, Party; Bocchia, Monica
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype
1998-01-01 Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F.
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype
1998-01-01 Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F.
Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia
2015-01-01 Gugliotta, Gabriele; Castagnetti, Fausto; Breccia, Massimo; Levato, Luciano; D’Adda, Mariella; Stagno, Fabio; Tiribelli, Mario; Salvucci, Marzia; Fava, Carmen; Martino, Bruno; Cedrone, Michele; Bocchia, Monica; Trabacchi, Elena; Cavazzin, Francesco; Usala, Emilio; Rossi, Antonella Russo; Bochicchio, Maria Teresa; Soverini, Simona; Alimena, Giuliana; Cavo, Michele; Pane, Fabrizio; Martinelli, Giovanni; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases | 1-gen-1990 | Zinzani, P. L.; Lauria, F.; Buzzi, M.; Raspardori, D.; Gugliotta, L.; Bocchia, M.; Macchi, S.; Algeri, R.; Tura, S. | - | |
| Hematological findings in adult T-cell lymphoma by cytofluorographic analysis. Correlation with histopathology, ultrastructure and immunohistochemistry in 4 cases | 1-gen-1986 | Cintorino, M; Leoncini, L; DEL VECCHIO, Mt; DE SANTI, Mm; Lavarini, E; Musaró, Ma; Tarantino, C | - | |
| Hematological findings in B-cell lymphoma by cytofluorographic analysis. Correlation wtih morphological findings | 1-gen-1987 | Leoncini, L.; DEL VECCHIO, M. T.; Vindigni, C.; Lavarini, E.; Nuti, S.; Cantore, M.; Cintorino, M. | - | |
| High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2) | 1-gen-2020 | Mauro, F. R.; Molica, S.; Soddu, S.; Ilariucci, F.; Coscia, M.; Zaja, F.; Angelucci, E.; Re, F.; Liberati, A. M.; Tedeschi, A.; Reda, G.; Pietrasanta, D.; Gozzetti, A.; Battistini, R.; Del Poeta, G.; Musolino, C.; Nanni, M.; Piciocchi, A.; Vignetti, M.; Neri, A.; Albano, F.; Cuneo, A.; Giudice, I. D.; Starza, I. D.; de Propris, M. S.; Raponi, S.; Guarini, A. R.; Foa, R. | - | |
| Higher levels of reactive oxygen species are associated with anergy in chronic lymphocytic leukemia | 1-gen-2015 | Linley, Adam; Valle Argos, Beatriz; Steele, Andrew J.; Stevenson, Freda K.; Forconi, Francesco; Packham, Graham | - | |
| HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: Impact of the HLA-G 14 base pair (rs66554220) polymorphism | 1-gen-2014 | Rizzo, Roberta; Audrito, Valentina; Vacca, Paola; Rossi, Davide; Brusa, Davide; Stignani, Marina; Bortolotti, Daria; D'Arena, Giovanni; Coscia, Marta; Laurenti, Luca; Forconi, Francesco; Gaidano, Gianluca; Mingari, Maria Cristina; Moretta, Lorenzo; Malavasi, Fabio; Deaglio, Silvia | - | |
| Hodgkin's disease: Update of findings | 1-gen-1991 | Pileri, S.; Sabattini, E.; Tazzari, P. L.; Gherlinzoni, F.; Zucchini, L.; Bigerna, B.; Leoncini, L.; Rosso, R.; Stein, H.; Falini, B. | - | |
| Hodgkin’s disease: summary of twenty years of experience | 1-gen-1992 | Mazza, P.; Bocchia, M.; Zinzani, P. L.; Fiacchini, M.; Gherlinzoni, F.; Bandini, G.; Bendandi, M.; Frezza, G. P.; Neri, S.; Barbieri, E.; Tura, S. | - | |
| How do patients with aggressive non-Hodgkin lymphoma’s treated with third generation regimens fare in the long term? | 1-gen-1999 | Zinzani, P. L.; Martelli, M.; Magagnoli, M.; Zaja, F.; Storti, S.; Pavone, E.; Lauta, V. M.; DE RENZO, Amalia; Gobbi, M.; Bocchia, M.; Ronconi, F.; Scaramucci, L.; Gherlinzoni, F.; Palombi, F.; Bendandi, M.; Stefoni, V.; ANTICOLI BORZA, P.; Cellini, C.; Mandelli, F.; Tura, S. | - | |
| IGHV1 status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course (Comment to Giudice ID, Foà R. Haematologica. 2019;104(2):219-221) | 1-gen-2019 | Amato, T.; Granai, M.; Leoncini, L.; Bellan, C. | - | |
| Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an Italian Multicentric Phase II Study | 1-gen-2007 | Leoncini, Lorenzo; Rondoni, M; Arpinati, M; Paolini, S; Candoni, A; Fanin, R; Messa, E; Pirrotta, MARIA TERESA; Lauria, F.; Visani, G; Alberti, D; Rancati, F; Vinaccia, V; Russo, D; Saglio, G; Baccarani, M; Martinelli, G | - | |
| Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification | 1-gen-2017 | Sutton, Lesley Ann; Hadzidimitriou, Anastasia; Baliakas, Panagiotis; Agathangelidis, Andreas; Langerak, Anton W; Stilgenbauer, Stephan; Pospisilova, Sarka; Davis, Zadie; Forconi, Francesco; Davi, Frederic; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas | - | |
| Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome | 1-gen-2019 | Benagiano, Marisa; Borghi, Maria Orietta; Romagnoli, Jacopo; Mahler, Michael; Della Bella, Chiara; Grassi, Alessia; Capitani, Nagaja; Emmi, Giacomo; Troilo, Arianna; Silvestri, Elena; Emmi, Lorenzo; Alnwaisri, Heba; Bitetti, Jacopo; Tapinassi, Simona; Prisco, Domenico; Baldari, Cosima; Meroni, Pier Luigi; D'Elios, Mario Milco | - | |
| Intracytoplasmatic and intranuclear filamentous inclusions in a case of acute monocytic leukemia | 1-gen-1986 | Leoncini, L.; Del Vecchio, M. T.; de Santi, M. M.; Cantore, M.; Tarantino, C. | - | |
| Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia? | 1-gen-2002 | Bocchia, M.; Gentili, S.; Lauria, F. | - | |
| Localized orbital lymphoma | 1-gen-1997 | Galieni, P.; Polito, E.; Leccisotti, A.; Marotta, G.; Lasi, S.; Bigazzi, C.; Bucalossi, A.; Frezza, G.; Lauria, F. | - | |
| The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: The GIMEMA CML Working Party experience after a 7-year follow-up | 1-gen-2009 | Palandri, Francesca; Castagnetti, Fausto; Alimena, Giuliana; Testoni, Nicoletta; Breccia, Massimo; Luatti, Simona; Rege Cambrin, Giovanna; Stagno, Fabio; Specchia, Giorgina; Martino, Bruno; Levato, Luciano; Merante, Serena; Liberati, Anna Maria; Pane, Fabrizio; Saglio, Giuseppe; Alberti, Daniele; Martinelli, Giovanni; Baccarani, Michele; Rosti, Gianantonio; GIMEMA CML Working, Party; Bocchia, Monica | - | |
| Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype | 1-gen-1998 | Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F. | - | |
| Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype | 1-gen-1998 | Marotta, G.; Bigazzi, C.; Bocchia, M.; Forconi, F.; Lauria, F. | - | |
| Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia | 1-gen-2015 | Gugliotta, Gabriele; Castagnetti, Fausto; Breccia, Massimo; Levato, Luciano; D’Adda, Mariella; Stagno, Fabio; Tiribelli, Mario; Salvucci, Marzia; Fava, Carmen; Martino, Bruno; Cedrone, Michele; Bocchia, Monica; Trabacchi, Elena; Cavazzin, Francesco; Usala, Emilio; Rossi, Antonella Russo; Bochicchio, Maria Teresa; Soverini, Simona; Alimena, Giuliana; Cavo, Michele; Pane, Fabrizio; Martinelli, Giovanni; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile